Other Specified Feeding or Eating Disorder Clinical Trials
2 recruiting trials for Other Specified Feeding or Eating Disorder. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Other Specified Feeding or Eating Disorder clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Texas Southwestern Medical Center (1), Fundació Sant Joan de Déu (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Educational (behavioral, 1 trial), followed by Interactive, ED-MINERVA Program.
Track Other Specified Feeding or Eating Disorder trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Targeting Social Function in Anxiety and Eating Disorders
Social processing and cognition are often altered in patients with eating disorders. The goal of this clinical trial is to assess two different social therapeutic interventions --...
Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program
The aim of this study is to investigate the efficacy, efficiency, and patient experience of a new intervention program on adolescents with high-complexity eating disorders (ED). A...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Other Specified Feeding or Eating Disorder, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Other Specified Feeding or Eating Disorder, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Other Specified Feeding or Eating Disorder, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.